Search Results - Franck Slowinski
- Showing 1 - 3 results of 3
-
1
The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents by Guy Griebel, Jeanne Stemmelin, Mati Lopez‐Grancha, Valérie Fauchey, Franck Slowinski, Philippe Pichat, Gihad Dargazanli, Ahmed Abouabdellah, Caroline Cohen, Olivier Bergis
Published 2018Artigo -
2
The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in ro... by Guy Griebel, Jeanne Stemmelin, Mati Lopez‐Grancha, Denis Boulay, Gérald Boquet, Franck Slowinski, Philippe Pichat, Sandra Beeské, Shinji Tanaka, Akiko Mori, Masatake Fujimura, Junichi Eguchi
Published 2019Artigo -
3
The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia by Guy Griebel, Philippe Pichat, Denis Boulay, Vanessa Naimoli, Lisa Potestio, Robert E. Featherstone, Sukhveen Sahni, Henry Defex, Christophe Desvignes, Franck Slowinski, Xavier Vigé, Olivier Bergis, Rosy Sher, Raymond W. Kosley, Sathapana Kongsamut, Mark D. Black, Geoffrey B. Varty
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Neuroscience
Pharmacology
Psychology
Agonist
Biochemistry
Internal medicine
Psychiatry
Receptor
Allosteric modulator
Alzheimer's disease
Anandamide
Antidepressant
Anxiety
Anxiolytic
Behavioural despair test
Biology
Cannabinoid
Cannabinoid receptor
Cell biology
Chemistry
Chronic stress
Disease
Endocannabinoid system
Fatty acid amide hydrolase
GSK-3
GSK3B
Gene
Genetically modified mouse
Glutamate receptor